Hemal Mehta

2.2k total citations
60 papers, 1.4k citations indexed

About

Hemal Mehta is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Hemal Mehta has authored 60 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Ophthalmology, 46 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Molecular Biology. Recurrent topics in Hemal Mehta's work include Retinal Diseases and Treatments (51 papers), Retinal Imaging and Analysis (41 papers) and Retinal and Optic Conditions (32 papers). Hemal Mehta is often cited by papers focused on Retinal Diseases and Treatments (51 papers), Retinal Imaging and Analysis (41 papers) and Retinal and Optic Conditions (32 papers). Hemal Mehta collaborates with scholars based in United Kingdom, Australia and Switzerland. Hemal Mehta's co-authors include Mark C. Gillies, Vuong Nguyen, Daniel Barthelmes, Samantha Fraser‐Bell, Adnan Tufail, Aaron Lee, Mehmet Öztürk, Vincent Daïen, Mandeep S. Sagoo and Victoria M.L. Cohen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Cochrane Database of Systematic Reviews.

In The Last Decade

Hemal Mehta

58 papers receiving 1.4k citations

Peers

Hemal Mehta

OPHTH

RNMI

NEURO

PFM

Claudia Weiß Germany

Chuandi Zhou China

María H. Berrocal Puerto Rico

Satoko Eguchi Japan

Nathan Steinle United States

Carola Metzig Germany

Cynthia R. Stockdale United States

Ding Xu China

Namrata Saroj United States

Andreas Weichselberger Switzerland

Claudia Weiß Germany

Hemal Mehta

629 ×0.5

OPHTH

658 ×0.7

RNMI

196 ×1.4

NEURO

118 ×1.0

35 ×0.3

PFM

Citations per year, relative to Hemal Mehta Hemal Mehta (= 1×) peers Claudia Weiß

Countries citing papers authored by Hemal Mehta

Since Specialization

Citations

This map shows the geographic impact of Hemal Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hemal Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hemal Mehta more than expected).

Fields of papers citing papers by Hemal Mehta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hemal Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hemal Mehta. The network helps show where Hemal Mehta may publish in the future.

Co-authorship network of co-authors of Hemal Mehta

This figure shows the co-authorship network connecting the top 25 collaborators of Hemal Mehta. A scholar is included among the top collaborators of Hemal Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hemal Mehta. Hemal Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chang, John H., Hemal Mehta, Samantha Fraser‐Bell, et al.. (2025). A prospective, open-label, single-arm, investigator-initiated clinical trial to assess the efficacy, safety and durability of faricimab in patients with inadequate response to current treatment for neovascular age-related macular degeneration: protocol design and rationale for the FURGGHORN Study. BMJ Open Ophthalmology. 10(1). e002326–e002326.

Hashimoto, Yohei, Alessandro Invernizzi, Pierre‐Henry Gabrielle, et al.. (2024). Outliers of Treatment Frequency in Retinal Vein Occlusion: 24‐Month Comparative Analysis of Fight Retinal Blindness! Practitioners. Clinical and Experimental Ophthalmology. 53(4). 409–420.

Hunt, Adrian, Carolina Arruabarrena, Hemal Mehta, et al.. (2024). Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry. Scientific Reports. 14(1). 6122–6122. 1 indexed citations

Yuen, Yew Sen, Jagjit S. Gilhotra, Michelle Dalton, et al.. (2023). Diabetic Macular Oedema Guidelines: An Australian Perspective. Journal of Ophthalmology. 2023(1). 6329819–6329819. 3 indexed citations

Cornish, Elisa E., Sanjeewa Wickremasinghe, Hemal Mehta, et al.. (2023). Aflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO). Eye. 37(16). 3417–3422. 2 indexed citations

Mehta, Hemal, et al.. (2023). Novel Drug Delivery Methods and Approaches for the Treatment of Retinal Diseases. Asia-Pacific Journal of Ophthalmology. 12(4). 402–413. 8 indexed citations

Gabrielle, Pierre‐Henry, Hemal Mehta, Daniel Barthelmes, et al.. (2023). From randomised controlled trials to real-world data: Clinical evidence to guide management of diabetic macular oedema. Progress in Retinal and Eye Research. 97. 101219–101219. 7 indexed citations

Hunt, Adrian, Vuong Nguyen, S. Bhandari, et al.. (2022). Central Retinal Vein Occlusion 36-Month Outcomes with Anti-VEGF. Ophthalmology Retina. 7(4). 338–345. 6 indexed citations

Balaskas, Konstantinos, Winfried M. K. Amoaku, Louise Downey, et al.. (2021). Importance of Anatomical Efficacy for Disease Control in Neovascular AMD: An Expert Opinion. Ophthalmology and Therapy. 10(2). 231–243. 7 indexed citations

10.

Mehta, Hemal, et al.. (2021). The ocular adverse effects of oral drugs. Australian Prescriber. 44(4). 129–136. 8 indexed citations

11.

McCafferty, Kieran, Ben Caplin, Paul Hockings, et al.. (2020). HEROIC: a 5-year observational cohort study aimed at identifying novel factors that drive diabetic kidney disease: rationale and study protocol. BMJ Open. 10(9). e033923–e033923. 1 indexed citations

12.

Mehta, Hemal, et al.. (2020). <p>Trends in Real-World Neovascular AMD Treatment Outcomes in the UK</p>. Clinical ophthalmology. Volume 14. 3331–3342. 32 indexed citations

13.

Mehta, Hemal, Adnan Tufail, Vincent Daïen, et al.. (2018). Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors. Progress in Retinal and Eye Research. 65. 127–146. 199 indexed citations

14.

Mehta, Hemal, Samantha Fraser‐Bell, Vuong Nguyen, Lyndell L. Lim, & Mark C. Gillies. (2017). The Interval between Treatments of Bevacizumab and Dexamethasone Implants for Diabetic Macular Edema Increased over Time in the BEVORDEX Trial. Ophthalmology Retina. 2(3). 231–234. 11 indexed citations

15.

Wickremasinghe, Sanjeewa, et al.. (2017). Retinal vascular calibre changes after intravitreal bevacizumab or dexamethasone implant treatment for diabetic macular oedema. British Journal of Ophthalmology. 101(10). 1329–1333. 12 indexed citations

16.

Pakzad-Vaezi, Kaivon, Hemal Mehta, Zaid Mammo, & Adnan Tufail. (2016). Vascular endothelial growth factor inhibitor use and treatment approach for choroidal neovascularization secondary to pathologic myopia. Expert Opinion on Biological Therapy. 16(7). 873–881. 2 indexed citations

17.

Fraser‐Bell, Samantha, Lyndell L. Lim, Anna Campain, et al.. (2016). Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study). Ophthalmology. 123(6). 1399–1401. 58 indexed citations

18.

Mehta, Hemal, et al.. (2016). Optical coherence tomography imaging of optic disc cavernous haemangioma. Journal of Clinical Neuroscience. 33. 234–235. 3 indexed citations

19.

Lee, Cecilia S., Aaron Lee, Dawn A. Sim, et al.. (2014). Reevaluating the Definition of Intraretinal Microvascular Abnormalities and Neovascularization Elsewhere in Diabetic Retinopathy Using Optical Coherence Tomography and Fluorescein Angiography. American Journal of Ophthalmology. 159(1). 101–110.e1. 57 indexed citations

20.

Mehta, Hemal, et al.. (2012). AUTOFLUORESCENCE AND SPECTRAL-DOMAIN OCT FINDINGS IN AN ATROPHIC MACULOPATHY ASSOCIATED WITH PSEUDOXANTHOMA ELASTICUM. UCL Discovery (University College London). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact